Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Rundback

Vascular & Interventional Radiology Teaneck, NJ Medical Doctor

NPI 1255367280 CMS profile 102489

718 Teaneck Rd, Teaneck, NJ 07666

Open in the dashboard

General payments

$507,495

729 records reported · program years 2019–2025

Research payments

$29,699

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$618,357 paid to institutions, not to them · program years 2019–2025

Through program year 2025, John Rundback of Teaneck, NJ is reported in the CMS Open Payments database as having received $507,495 across 729 general payments and $29,699 in research payments paid to them. Separately, studies naming them as principal investigator received $618,357 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,455 76
2024 General $45,113 84
2023 General $50,202 102
2023 Research $1,000 1
2022 General $122,816 150
2021 General $100,229 102
2021 Research $12,318 2
2020 General $78,519 86
2020 Research $16,381 3
2019 General $56,160 129

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Rundback
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to John Rundback were reported at $54,455. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year John Rundback Vascular & Interventional Radiology median Middle half National median
2019 $56,160 $422 $125–$1,555 $163
2020 $78,519 $200 $68–$652 $114
2021 $100,229 $280 $99–$866 $132
2022 $122,816 $433 $137–$1,497 $149
2023 $50,202 $506 $152–$2,019 $160
2024 $45,113 $556 $175–$1,930 $164
2025 $54,455 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $209,561 122 payments
  2. Cardiovascular Systems Inc. $72,358 129 payments
  3. Inari Medical, Inc. $45,693 46 payments
  4. Abbott Laboratories $39,164 78 payments
  5. Bard Peripheral Vascular, Inc. $33,834 41 payments
  6. Medtronic, Inc. $27,380 67 payments
  7. Philips Electronics North America Corporation $20,775 34 payments
  8. Janssen Pharmaceuticals, Inc $15,035 23 payments
  9. Medtronic Vascular, Inc. $8,061 24 payments
  10. Shockwave Medical, Inc $6,560 12 payments
  11. Other $29,074 153 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $208,427 92 payments
  2. Long term medical supply or device loan $75,172 12 payments
  3. Education $49,492 7 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $47,425 19 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $42,828 16 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $25,478 12 payments
  7. Food and Beverage $24,467 469 payments
  8. Travel and Lodging $23,521 96 payments
  9. Honoraria $10,685 6 payments
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Et $78,816 12 payments
  2. CT THROMBECTOMY SYSTEM KIT $59,779 53 payments
  3. AURYON LASER SYSTEM 100-120 VAC Pad $40,461 73 payments
  4. Peripheral Orbital Atherectomy System $37,369 71 payments
  5. Diamondback Peripheral $32,081 52 payments
  6. FLOWTRIEVER CATHETER, S $29,038 41 payments
  7. ANGIOVAC $18,145 11 payments
  8. SUPERA $15,843 11 payments
  9. XARELTO $15,035 23 payments
  10. Auryon $15,000 1 payment
  11. Other $188,262 394 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $12,541 1 payment
  2. Veryan Medical Incorporated $12,318 2 payments
  3. AngioDynamics, Inc. $3,575 1 payment
  4. Asahi Intecc USA, Inc. $1,000 1 payment
  5. Cook Research Incorporated $265 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

795

Median for Interventional Radiology: 38

Drug cost

$176,346

Median for Interventional Radiology: $333

Branded share of claims

46.5%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 165 $144,214
Eliquis Apixaban Brand 16 $20,710
Cilostazol Generic 175 $5,364
Pentoxifylline Generic 40 $1,788
Clopidogrel Clopidogrel Bisulfate Brand 165 $1,317
Gabapentin Generic 64 $1,058
Atorvastatin Calcium Generic 83 $857
Nifedipine Er Nifedipine Brand 13 $337
Ammonium Lactate Generic 15 $325
Doxycycline Hyclate Generic 23 $214

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 120 billing codes

Paid by Medicare

$254,815

Of which drugs: $582

Medicare patients

321

Average age 75

Services billed

2,617

168 women, 153 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 65%
Arthritis 61%
Ischemic heart disease 53%
Chronic kidney disease 45%
Heart failure 39%
COPD 29%
Atrial fibrillation 28%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 12 1,550 $163

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$17 165 —
NUZYRA
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

735 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record